ST Pharm
ST Pharm
  • 01Who we are
  • 02Our record
  • 03Newsroom
  • 04Contact
    • En
    • Ko
ST Pharm
  • Science & Technology
    • Business Overview사업영역
    • CDMO위탁생산개발
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO위탁임상서비스
      • AnaPath Research & Service
    • R&D연구개발
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • 핵심인력
    • 연혁
    • Global 인증
    • 자회사
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
Public
Notice
  • PR (Public Relations)
    • News room
      • All
      • Media Focus
      • ST PHARM News
  • IR (Investor Relations)
    • Stock Information
    • IR Library
      • Disclosure Information
      • IR Materials
      • Notice

IR Library

  • Disclosure Information
  • IR Materials
  • Notice
에스티팜 외국인 지분율에 대하여Oct 28, 2021
[공시] 국민연금, 에스티팜 지분 5.03% 보유Oct 6, 2021
[공시] 거래처의 추가 생산 요청으로 공급계약 금액 증가Sep 27, 2021
에스티팜, 1분기 잠정 연결 영업이익 -65억원, 적자축소Apr 28, 2021
[안내] 2020년 사업보고서 제출 안내 Mar 15, 2021
[안내] 전환사채의 전환권 행사에 따른 신주 추가상장Jan 3, 2021
[안내] MRI조영제 제네릭 단일판매 공급계약 관련 추가 정보입니다.Aug 23, 2019
[공지] 전자증권 전환 대상 주권 권리자(주주) 보호 및 조치사항 안내 Aug 6, 2019
내부정보관리규정 Aug 25, 2017
2of2
HOMEPublicIR (Investor Relations)IR LibraryNotice
  • Science & Technology
    • Business Overview사업영역
    • CDMO위탁생산개발
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO위탁임상서비스
      • AnaPath Research & Service
    • R&D연구개발
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • 핵심인력
    • 연혁
    • Global 인증
    • 자회사
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
© 2023 ST Pharm. All rights reserved.
  • Sitemap
  • Contact